{"id":"W2570376902","doi":"10.1097/fpc.0000000000000263","title":"Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202","year":2017,"lang":"en","type":"article","venue":"Pharmacogenetics and Genomics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences; National Human Genome Research Institute; Public Health Agency of Canada","keywords":"Efavirenz; Internal medicine; Genome-wide association study; Clinical trial; Medicine; Pharmacogenetics; Oncology; Biology; Single-nucleotide polymorphism; Viral load; Human immunodeficiency virus (HIV); Immunology; Genetics; Antiretroviral therapy; Genotype; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01458016,0.001591211,0.001602432,0.0007818144,0.00156061,0.001085173,0.00236999,0.002496433,0.03705348],"category_scores_gemma":[0.02320902,0.0007515533,0.0008821557,0.002752852,0.000594223,0.001301443,0.0009897283,0.002132108,0.01209309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008344133,"about_ca_system_score_gemma":0.003694613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001270157,"about_ca_topic_score_gemma":0.002781707,"domain_scores_codex":[0.9843869,0.01177533,0.001238476,0.001415218,0.000681852,0.0005021571],"domain_scores_gemma":[0.9829573,0.005269918,0.002914057,0.004636785,0.002612344,0.001609476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3807932,0.00369799,0.1396567,0.007830343,0.004439784,0.002331586,0.0009018041,0.002912569,0.01146545,0.009609089,0.3783931,0.05796837],"study_design_scores_gemma":[0.2782842,0.0255137,0.3941479,0.003071559,0.003331868,0.001505483,0.0005318175,0.00955742,0.003345371,0.01188606,0.2685206,0.0003040101],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"empirical","genre_scores_codex":[0.1386106,0.00214354,0.02014251,0.00585794,0.002236509,0.4784264,0.3118147,0.0009322755,0.03983552],"genre_scores_gemma":[0.2495966,0.001049636,0.03031896,0.005871457,0.0009905177,0.5824276,0.1073164,0.0002818006,0.02214706],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03705348,"threshold_uncertainty_score":0.1239563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1053613391183971,"score_gpt":0.4594565667727651,"score_spread":0.354095227654368,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}